Safety and efficacy of two pangenotypic direct acting antivirals (sofosbuvir/velpatasvir and glecaprevir/pibrentasvir) for the treatment of hepatitis C in children

被引：0
|
作者：
Pokorska-Sprimepiewak, Maria [1 ]
Talarek, Ewa [2 ]
Dobrzeniecka, Anna [3 ]
Aniszewska, Malgorzata [2 ]
Pluta, Magdalena [2 ]
Marczynska, Magdalena [2 ]
机构：
[1] Med Univ Warsaw, Reg Hosp Infect Dis, Warsaw, Poland
[2] Med Univ Warsaw, Reg Hosp Infect Dis Warsaw, Warsaw, Poland
[3] Reg Hosp Infect Dis Warsaw, Warsaw, Poland
来源：
JOURNAL OF HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-387
引用
收藏
页码：S820 / S821
页数：2
相关论文
共 50 条
  • [1] Review article: novel antivirals for hepatitis C-sofosbuvir/velpatasvir/voxilaprevir, glecaprevir/pibrentasvir
    Pearlman, Brian L.
    Hinds, Andrew E.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (09) : 914 - 923
  • [2] EXCELLENT EFFICACY AND SAFETY OF SOFOSBUVIR, GLECAPREVIR, PIBRENTASVIR AND RIBAVIRIN FOR RETREATMENT OF CHRONIC HEPATITIS C AFTER SOFOSBUVIR, VELPATASVIR AND VOXILAPREVIR FAILURE
    Saxena, Varun
    McKinney, Jeff
    Chamberland, Scott
    Catalli, Lisa
    Seo, Suk
    Ready, Joanna B.
    Price, Jennifer C.
    HEPATOLOGY, 2021, 74 : 66A - 67A
  • [3] Sofosbuvir/Velpatasvir: The First Pangenotypic Direct-Acting Antiviral Combination for Hepatitis C
    Chahine, Elias B.
    Sucher, Allana J.
    Hemstreet, Brian A.
    ANNALS OF PHARMACOTHERAPY, 2017, 51 (01) : 44 - 53
  • [4] Sofosbuvir/Velpatasvir/Voxilaprevir for Previous Treatment Failures With Glecaprevir/Pibrentasvir in Chronic Hepatitis C Infection
    Pearlman, Brian
    Perrys, Michael
    Hinds, Andrew
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 (09): : 1550 - 1552
  • [5] Real-world effectiveness and safety of sofosbuvir/velpatasvir and glecaprevir/ pibrentasvir for genotype 6 chronic hepatitis C
    Chen, Jyh-Jou
    Chiu, Yen-Cheng
    Lee, Pei-Lun
    Tung, Hung-Da
    Chiu, Hung-Chih
    Chien, Shih-Chieh
    Cheng, Pin-Nan
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2022, 121 (11) : 2265 - 2272
  • [6] Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir
    Ruiz-Cobo, Juan Carlos
    Llaneras, Jordi
    Forns, Xavier
    Gallego Moya, Adolfo
    Conde Amiel, Isabel
    Arencibia, Ana
    Diago, Moises
    Garcia-Samaniego, Javier
    Castellote, Jose
    Llerena, Susana
    Rodriguez-Seguel, Elisa
    Mateos, Beatriz
    Rodriguez, Manuel
    Rosales Zabal, Jose Miguel
    Fernandez, Inmaculada
    Calleja, Jose Luis
    Morillas, Rosa Maria
    Montoliu, Silvia
    Andrade, Raul J.
    Badia Aranda, Ester
    Hernandez-Guerra, Manuel
    Mate, Carlota Jimeno
    Gonzalez-Santiago, Jesus M.
    de Cuenca, Beatriz
    Bernal-Monterde, Vanesa
    Delgado, Manuel
    Turnes, Juan
    Lens, Sabela
    Buti, Maria
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (02) : 201 - 211
  • [7] Real-life effectiveness of voxilaprevir/sofosbuvir/velpatasvir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir
    Ruiz-Cobo, Juan Carlos
    Llaneras, Jordi
    Buti, Maria
    Forns, Xavier
    Conde, Isabel
    Arencibia Almeida, Ana
    Diago, Moises
    Garcia-Samaniego Rey, Francisco Javier
    Castellote Alonso, Jose
    Llerena, Susana
    Rodriguez, Elisa
    Mateos Munoz, Beatriz
    Rodriguez, Manuel
    Fernandez Vazquez, Inmaculada
    Rosales Zabal, Jose Miguel
    Calleja Panero, Jose Luis
    Morillas, Rosa M.
    Montoliu, Silvia
    Gallego Moya, Adolfo
    Andrade, Raul J.
    Hernandez Guerra, Manuel
    Badia-Aranda, Esther
    Jimeno Mate, Carlota
    Gonzalez Santiago, Jesus
    Cuenca, Beatriz
    Bernal Monterde, Vanesa
    Delgado, Manuel
    Turnes, Juan
    Lens, Sabela
    JOURNAL OF HEPATOLOGY, 2023, 78 : S1205 - S1206
  • [8] Real-World Safety and Effectiveness of Sofosbuvir/Velpatasvir/Voxilaprevir and Glecaprevir/Pibrentasvir in Hepatitis C Infected Patients
    Saxena, Varun
    Chamberland, Scott
    Hurley, Leo
    Lai, Jennifer B.
    Truong, Elizabeth
    Marcus, Julia
    Champsi, Jamila
    Hare, Brad B.
    Korn, Daniel
    Ready, Joanna B.
    Seo, Suk
    Witt, David J.
    Silverberg, Michael J.
    HEPATOLOGY, 2018, 68 : 418A - 419A
  • [9] A comparison of sofosbuvir/velpatasvir and glecaprevir/pibrentasvir for the treatment of hepatitis C infection among people who inject drugs
    Yi, Shana
    Truong, David
    Conway, Brian
    JOURNAL OF VIRUS ERADICATION, 2024, 10 (03)
  • [10] SOFOSBUVIR/VELPATASVIR VS GLECAPREVIR/PIBRENTASVIR IN GENOTYPE 3 HEPATITIS C VIRUS INFECTED PATIENTS
    Margusino-Framinan, L.
    Cid-Silva, P.
    Rotea-Salvo, S.
    Mena-de-Cea, A.
    Delgado, M.
    Vazquez-Rodriguez, P.
    Sanclaudio-Luhia, I
    Suarez-Lopez, F.
    Herranz, I
    Castro-Iglesias, A.
    VALUE IN HEALTH, 2019, 22 : S640 - S640
12345